With a mega 10-million-euro investment, IFF has expanded its LMR Naturals site in Grasse, France. With this move, the company brings together more than 30 research and development experts under one roof, enhancing the firm’s ability to meet the growing global demand for traceable, sustainable and high-quality naturals.

Developed by CAC Engineering, Bondalti Chemicals’ facility made use of Asahi Kasei’s chlor-alkali electrolysis technology. The new unit will also be utilized for further reducing power consumption and optimizing the use of materials in the chlor-alkali industry.

Vioneo is taking a major step toward fossil-free production with a groundbreaking plant in Antwerp powered by green methanol. Partnering with engineering firm Wood, the project aims to deliver the world’s first industrial-scale, carbon-negative plastics

The hydrogen evolution reaction (HER) is a remarkable process that can create clean hydrogen fuel — a potential part of a solution to our climate change crisis. The problem lies in scaling up this reaction from a lab experiment to large scale commercial production, while keeping costs down.

Roche has recently signed a definitive merger agreement to acquire 89bio, a clinical-stage biopharma firm specializing in the development of innovative therapies for the treatment of liver and cardiometabolic diseases.

Everyone has heard about the ‘Metaverse’ concept but what exactly is the technology all about? Many would state that the Metaverse technology is the next level of digital transformation and this may well be true. Industry players are now not only keen to know more about the Metaverse technology but are also willing to explore the smart technology into their industrial plants and processes in the future. The supporting technologies and immersive environment of the technology offers numerous benefits for industrial plants. Read on to know more…

Eneos has awarded an EPC contract to Chiyoda for a large-scale Direct Methylcyclohexane electrosynthesis demonstration plant. The unit is expected to identify obstacles for future social implementation of Green MCH production technology.

With a mega investment of 6.5 billion dollars, Eli Lilly and Company has plans to develop a next-generation synthetic medicine active pharmaceutical product facility in Texas, USA. The facility will focus on manufacturing the company's pipeline of small molecule medicines across therapeutic areas.

Under an agreement signed between both the parties, RWE will build as well as operate a 300 MW electrolyzer to produce green hydrogen and Total Energies will supply 30,000 tons a year of green hydrogen to the Leuna refinery in Germany for fifteen years.

Schubert has expanded its ‘4You Service’ portfolio and now offers its customers measurable benefits in terms of efficiency, availability and sustainability – both in analogue and digital form.